By Meg Nash, Bridgette Nikisher
Nov 1, 2023
The clock is ticking—Maryland’s Social Equity Verification Portal will close on Tuesday, November 7. Have you completed your verification application? We recommend doing so as soon as possible to ensure that the Office of Social Equity has time to review your application and certify your social equity status.
By David Ullian
Oct 31, 2023
The Massachusetts Cannabis Control Commission’s amended regulations make substantial changes to the current regulatory framework related to HCAs, Social Equity businesses, municipal equity, and agent suitability. These changes reveal a clear intent to make real progress towards achieving the goals of creating new opportunities and a level playing field for Social Equity businesses, and continuing to build a successful, equitable cannabis industry in Massachusetts. Read this article for an overview of the key provisions in the amended regulations.
By David M. Ullian
Oct 26, 2023
Washington, D.C. recently expanded its medical cannabis program to increase medical cannabis access for non-resident patients, update testing lab procedures, and expand social equity applicant criteria. Read this article for a summary of the expansion plus key business licensing application dates.
By Meg Nash
Oct 24, 2023
The Maryland Cannabis Administration (MCA) recently released new information about the upcoming licensing round, including application instructions, an evaluation worksheet, and application templates. MCA also published an FAQ page. Read on for a summary of key information.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Oct 24, 2023
As part of the pre-rulemaking process, the Colorado Department of Revenue's Natural Medicine Division began holding public “Listening Sessions” with the goal of gathering information from the public at large. The October sessions consisted of five, one-hour, online meetings focused on specific topics announced in advance. Read this article for a summary of the first five sessions.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.